Tetra-Pivaloyl ertugliflozin
| Product Name | Tetra-Pivaloyl ertugliflozin |
|---|---|
| Alternate Names | Ertugliflozin Impurities, Impurities of Ertugliflozin |
| CAT No. | CS-O-32487 |
| CAS No. | 2161341-44-0 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 773.35 g/mol |
| Mol. For. | C42H57ClO11 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Ertugliflozin |
| Purity | >98 |
| Therapeutic | Anti-Diabetic |
| Smileys | CC(C)(C)C(OC[C@@]1(O2)[C@@H](OC(C(C)(C)C)=O)[C@H](OC(C(C)(C)C)=O)[C@@H](OC(C(C)(C)C)=O)[C@@]2(C3=CC=C(Cl)C(CC4=CC=C(OCC)C=C4)=C3)OC1)=O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Tetra-Pivaloyl ertugliflozin is a chemical compound used in the treatment of type 2 diabetes. It is a member of the SGLT2 inhibitor class of drugs, which work by inhibiting the function of the SGLT2 protein in the kidneys. This protein is responsible for reabsorbing glucose from the urine back into the bloodstream, which can lead to high blood sugar levels in people with diabetes. By inhibiting this protein, Tetra-Pivaloyl ertugliflozin helps to increase the amount of glucose that is excreted in the urine, thereby reducing blood sugar levels.
Chemically, Tetra-Pivaloyl ertugliflozin is a derivative of ertugliflozin, which is an SGLT2 inhibitor that was approved by the FDA in 2017. The addition of four pivaloyl groups to the ertugliflozin molecule increases its solubility and bioavailability, making it more effective at lower doses.
Tetra-Pivaloyl ertugliflozin is typically administered orally, in tablet form. It is important to follow the dosage instructions provided by a healthcare professional, as well as any other advice or recommendations regarding diet and exercise. As with all medications, there may be potential side effects associated with Tetra-Pivaloyl ertugliflozin, such as dehydration, urinary tract infections, and hypoglycemia. It is important to discuss any concerns or questions with a healthcare professional before starting treatment with this medication.
Get an Instant Quote
Related Compounds
Ertugliflozin L- pyroglutamic acid | Ertugliflozin aldehyde Impurity | Ertugliflozin Isomer Impurity | Ertugliflozin C4 epimer impurity | Methoxy diol Ertugliflozin | Ertugliflozin-Acid Impurity | Ertugliflozin Dimer Impurity | Ertugliflozin Des Hydroxy Impurity | Ertugliflozin-Anomer Impurity | Ertugliflozin Impurity 2 |